3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Interventional
4
Observational
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Breast Neoplasms
2229
Neoplasms
2031
Lung Neoplasms
1094
Colorectal Neoplasms
1033
Prostatic Neoplasms
892
Carcinoma, Non-Small-Cell Lung
751
Carcinoma, Hepatocellular
672
Stomach Neoplasms
606
Pancreatic Neoplasms
599
Head and Neck Neoplasms
433
Ovarian Neoplasms
430
Colonic Neoplasms
423
Rectal Neoplasms
406
Uterine Cervical Neoplasms
403
Esophageal Neoplasms
346
Brain Neoplasms
329
Neoplasm Metastasis
324
Melanoma
306
Multiple Myeloma
304
Precursor Cell Lymphoblastic Leukemia-Lymphoma
292
Urinary Bladder Neoplasms
289
Leukemia, Myeloid, Acute
276
Lymphoma
268
Liver Neoplasms
253
Endometrial Neoplasms
253
Hematologic Neoplasms
251
Disease
241
Recurrence
225
Glioma
217
Carcinoma, Renal Cell
207
Interventions
enzalutamide
1
Blood Specimen Collection
1
Biopsy
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Observational
×
Metastatic Castration Resistant Prostate Cancer
×
Clear all
NCT02471469
2020-10-19
ILUMINATE
Radboud University Medical Center
Completed
40 enrolled
NCT02426333
2019-09-13
OPTIMUM
Radboud University Medical Center
Completed
56 enrolled
NCT02424448
2016-07-26
BIOMETHS
The Christie NHS Foundation Trust
Completed
6 enrolled